Investor Overview Press Releases December 3, 2018 Aclaris Therapeutics Closes Acquisition of RHOFADE® (oxymetazoline hydrochloride) cream, 1% from Allergan November 28, 2018 Aclaris Therapeutics to Attend Upcoming Investor Conferences November 6, 2018 Aclaris Therapeutics Reports Third Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments View all » Events Nov 28, 20183:30 pm EST Aclaris Therapeutics, Inc at 30th Annual Piper Jaffray Healthcare Conference Nov 27, 20183:05 PM EST Aclaris Therapeutics, Inc. at Evercore ISI, HealthconX Nov 15, 20188:00 AM MST Aclaris Therapeutics, Inc. at Credit-Suisse 27th Annual Healthcare Conference View all » Feature presentation Aclaris Therapeutics Company Overview
December 3, 2018 Aclaris Therapeutics Closes Acquisition of RHOFADE® (oxymetazoline hydrochloride) cream, 1% from Allergan
November 6, 2018 Aclaris Therapeutics Reports Third Quarter 2018 Financial Results and Provides Update on Clinical and Commercial Developments
Nov 15, 20188:00 AM MST Aclaris Therapeutics, Inc. at Credit-Suisse 27th Annual Healthcare Conference
